Inverse association between metabolic dysfunction-associated steatotic liver disease and incident rheumatoid arthritis in middle-aged adults with chronic hepatitis B
Clinical Rheumatology · 2026-08 · 45 (8) · 4899-4908
DOI: 10.1007/s10067-026-08260-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Rheumatology, online erschienen am 03.07.2026. Verfasst von Junwon Park und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Korea University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Hepatitis B, Chronic, Fatty Liver. Die Arbeit nennt 42 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
INTRODUCTION: Chronic hepatitis B (CHB) frequently coexists with metabolic dysfunction-associated steatotic liver disease (MASLD). This study aimed to determine whether MASLD is a risk factor for incident rheumatoid arthritis among middle-aged patients with CHB in a real-world setting. METHOD: A population-based cohort study was conducted using the Korean National Health Insurance Service, including 114,425 middle-aged CHB individuals (aged 40-65 years) classified as having either MASLD or non-SLD. Cox proportional hazards regression and Fine-Gray subdistribution hazard models were applied to assess RA risk, accounting for all-cause mortality as a competing event. All patients were followed up until RA, death, or January 31, 2022. RESULTS: During 792,777 person-years of follow-up, 867 incident RA cases were identified. CHB patients with MASLD had a significantly lower risk of RA development compared to non-SLD participants (subdistribution hazard ratio [SHR], 0.82; 95% CI, 0.69-0.97). This effect was more obvious among younger aged patients (< 50 years). Additionally, higher daily alcohol consumption (1 g/day) was associated with an increased adjusted SHR for RA among all middle-aged CHB patients (1.007; 95% CI, 1.003-1.012). CONCLUSIONS: In middle-aged patients with CHB, the presence of MASLD was associated with a lower risk of developing RA. However, the underlying mechanisms remain unclear, and residual confounding by CHB severity, liver disease stage, or antiviral treatment may have contributed to the observed association. Further studies are warranted to clarify these potential mechanisms linking CHB, MASLD, and RA risk. Key Points • In a nationwide Korean cohort of 114,425 middle-aged adults with CHB, MASLD was associated with a lower incidence of seropositive rheumatoid arthritis compared with non-steatotic liver disease. • In patients with CHB, MASLD may represent a distinct clinical state whose meaning could differ from standalone MASLD because it may be intertwined with the CHB disease stage and immune milieu.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
- Department of Biomedical Informatics, Korea University College of Medicine, Seoul, Republic of Korea.
- Department of Biomedical Informatics, Korea University College of Medicine, Seoul, Republic of Korea. seogsongjeong@korea.ac.kr.
- Biomedical Research Center, Korea University Guro Hospital, Seoul, Republic of Korea. seogsongjeong@korea.ac.kr.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Park, J., Kang, E. S., & Jeong, S. (2026). Inverse association between metabolic dysfunction-associated steatotic liver disease and incident rheumatoid arthritis in middle-aged adults with chronic hepatitis B. Clinical Rheumatology, 45(8), 4899-4908. https://doi.org/10.1007/s10067-026-08260-2
Vancouver
Park J, Kang ES, Jeong S. Inverse association between metabolic dysfunction-associated steatotic liver disease and incident rheumatoid arthritis in middle-aged adults with chronic hepatitis B. Clinical Rheumatology. 2026;45(8):4899-4908. doi:10.1007/s10067-026-08260-2
BibTeX
@article{Park2026,
author = {Park, Junwon and Kang, Eun Seok and Jeong, Seogsong},
title = {Inverse association between metabolic dysfunction-associated steatotic liver disease and incident rheumatoid arthritis in middle-aged adults with chronic hepatitis B},
journal = {Clinical Rheumatology},
year = {2026},
volume = {45},
number = {8},
pages = {4899--4908},
doi = {10.1007/s10067-026-08260-2}
}
EUVIMED